Polycystic ovary syndrome. ICD-10 Chapter XV: Pregnancy, childbirth and the puerperium
Conditions
Interventions
Intervention 1: case group: under treatment with 500 mg Metformin tablets with the brand name Glucophage twice a day and 5 mg Progesterone tablets with the brand name Medrofem twice a day, both pills
Sponsors
Ilam University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to 50 Years
Inclusion criteria
Inclusion criteria: Women who have a proven history of polycystic ovary syndrome, tests, and ultrasound Clinical signs such as oligomenorrhea, irregular menstrual cycle and androgen-induced symptoms
Exclusion criteria
Exclusion criteria: History of ovarian surgery in the last three months use of antiepileptic drugs and glucocorticoids congenital adrenal hyperplasia hypothyroidism, hyperthyroidism
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of infertile women who have had a positive pregnancy. Timepoint: Positive fertility in the first month or the second month or the third month after starting to use inofolic powder. Method of measurement: Positive B-hcg test and ultrasound. | — |
Secondary
| Measure | Time frame |
|---|---|
| Increase the number and size of follicles. Timepoint: The first month, the second month and the third month after the start of inofolic powder. Method of measurement: sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohamad Ehsan Mozafari
Ilam University of Medical Sciences
Outcome results
None listed